Equity Components [Axis] Convertible Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Award Type [Axis] Employee Stock Option [Member] Warrant [Member] Short-term Debt, Type [Axis] Convertible Debentures [Member] Class of Stock [Axis] Series A 0% Convertible Preferred Stock [Member] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Restatement [Axis] Previously Reported [Member] Restatement Adjustment [Member] Measurement Input Type [Axis] Measurement Input, Price Volatility [Member] Measurement Input, Expected Term [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Dividend Rate [Member] Related Party [Axis] Dr. Richerson [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Separation Agreement [Member] Income Statement Location [Axis] Research And Development [Member] General And Administrative [Member] Consultant [Member] Plan Name [Axis] Financing 2013 [Member] Financing 2014 [Member] Financing 2015 [Member] Financings 2016 [Member] Financings 2017 [Member] Series B And Series C Preferred Stock [Member] Exchange Agreement [Member] Debt Instrument [Axis] Series B 0% Convertible Preferred Stock [Member] Series B Preferred Stock [Member] Investors [Member] Series A Convertible Preferred Stock [Member] Series A Preferred Stock [Member] Registration Rights Agreement [Member] Share Exchange Agreement [Member] Business Acquisition [Axis] Lewis & Clark Pharmaceuticals, Inc. [Member] Escrow Agreement [Member] Property, Plant and Equipment, Type [Axis] Office And Lab Equipment [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Securities Purchase Agreement [Member] Investor [Member] Long-term Debt, Type [Axis] Senior Convertible Debentures [Member] Range [Axis] Maximum [Member] 10% Convertible Promissory Notes [Member] Series D 0% Convertible Preferred Stock [Member] Series C 0% Convertible Preferred Stock [Member] Series C Preferred Stock [Member] Preferred Stock And Warrants [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Trading Symbol Document Period End Date Amendment Flag Current Fiscal Year End Date Entity's Reporting Status Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash Prepaid expenses Total current assets Office and lab equipment, net of accumulated depreciation of $3 and $2, respectively Intangible assets, net of accumulated amortization of $166 and $162, respectively Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Accounts payable Accrued expenses Convertible debentures, net of unamortized discount of $147 and $227, respectively Derivative liability Total current liabilities Total liabilities Commitments and contingencies Stockholders' deficit: Convertible preferred stock, par value $.0001 per share; 30,000,000 shares authorized, 495 and 495 shares issued and outstanding, respectively Common stock, par value $.0001 per share; 150,000,000 shares authorized, 12,333,929 and 10,888,929 shares issued and outstanding, respectively Additional paid-in capital Accumulated deficit Total stockholders' deficit Total liabilities and stockholders' deficit Office and lab equipment, accumulated depreciation Intangible assets, accumulated amortization Net of unamortized discount of, convertible debentures Convertible preferred stock, par value (in dollars per share) Convertible preferred stock, shares authorized Convertible preferred stock, shares issued Convertible preferred stock, shares outstanding Common stock, par value (in dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Operating expenses: Research and development General and administrative Total operating expenses Loss from operations Other income (expense): Gain on change in fair value of derivative liability Gain on conversion of debt Interest income (expense), net Loss before provision for income taxes Provision for income taxes Net loss Deemed dividend Net loss attributable to common shareholders Net loss per common share, basic and diluted (in dollars per share) Weighted average shares outstanding (in shares) Statement [Table] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Balance at beginning Balance at beginning (in shares) Stock-based compensation Conversion of preferred stock Conversion of preferred stock (in shares) Sale of preferred stock and warrants Sale of preferred stock and warrants (in shares) Preferred stock and warrants issued for services Preferred stock and warrants issued for services (in shares) Conversion of debentures Conversion of debentures (in shares) Net loss Balance at ending Balance at ending (in shares) Statement of Stockholders' Equity [Abstract] Share price (in dollars per share) Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Stock-based compensation Gain on change in fair value of derivative liability Gain on conversion of debt Amortization of debt discount (Increase) decrease in operating assets: Receivable for sale of preferred stock Prepaid expenses Increase in operating liabilities: Accounts payable and accrued expenses Cash used in operating activities Cash flows from investing activities: Acquisition of office equipment Cash used in investing activities Cash flows from financing activities: Proceeds from sale of stock and warrants Cash provided by financing activities Net decrease in cash Cash, beginning of period Cash, end of period Organization, Consolidation and Presentation of Financial Statements [Abstract] BACKGROUND Management Plans to Continue as Going Concern [Abstract] MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN Accounting Policies [Abstract] SUMMARY OF CRITICAL ACCOUNTING POLICIES AND USE OF ESTIMATES Supplemental Cash Flow Information [Abstract] SUPPLEMENTAL CASH FLOW INFORMATION Accrued Liabilities, Current [Abstract] ACCRUED EXPENSES Derivative Instruments and Hedging Activities Disclosure [Abstract] DERIVATIVE LIABILITY Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Stockholders' Equity Note [Abstract] CAPITAL STOCK AND STOCKHOLDERS' EQUITY Disclosure of Compensation Related Costs, Share-based Payments [Abstract] STOCK OPTIONS Warrants WARRANTS Debt Disclosure [Abstract] CONVERTIBLE DEBENTURES Business Combinations [Abstract] ACQUISITION Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Use of Estimates Research and Development Cash Equivalents Loss per Share Derivative Liability Fair Value of Financial Instruments Fair Value Measurements Stock-Based Compensation Effect of ASU No. 2017-11 on Previously Issued Financial Statements Recent Accounting Pronouncements Schedule of weighted average shares outstanding Schedule of fair values of financial liabilities Schedule of fair value of derivative liability on recurring basis Schedule of financial statements Schedule of additional information of cash flow Schedule of accrued expenses Schedule of black scholes valuations of derivatives Schedule of stock-based compensation expense Schedule of stock option activity Schedule of transactions involving of warrants Schedule of outstanding warrants to purchase common stock Schedule of final accounting Schedule of pro forma result of acquisition Proceeds from sale of debt securities Proceeds from sale of notes Cash and cash equivalents Shares underlying, outstanding Fair Value Hierarchy and NAV [Axis] Derivative liability Balance at beginning of year Additions to derivative instruments Reclassification on conversion Gain on change in fair value of derivative liability Balance at end of period Cash Receivable for sale of preferred stock Total current assets Office equipment, net of accumulated depreciation of $1 and $0 Intangible assets, net of accumulated amortization of $149 and $145 Other assets Total assets Total current liabilities Total liabilities Convertible preferred stock, par value $.0001 per share; 30,000,000 shares authorized, 2,957 shares issued and outstanding Common stock, par value $.0001 per share; 150,000,000 shares authorized, 1,532,417 shares issued and outstanding Total stockholders' deficit Total liabilities and stockholders' deficit Total operating expenses Loss from operations Loss before provision for income taxes Deemed dividend Net loss attributable to common shareholders Gain on change in fair value of derivative liability Finance cost Increase in operating assets: Receivable for sale of preferred stock Cash used in operating activities Cash used in investing activities Cash provided by financing activities Net decrease in cash Cash, beginning of period Cash, end of period Non-cash financial activities: Common stock issued on conversion of notes payable Debentures converted to common stock Derivative liability extinguished upon conversion of notes payable Preferred stock and warrants issued for fees Accrued compensation and benefits Accrued research and development Accrued other Total accrued expenses Derivative liability measurement input Gain on change in fair value of the derivative liability Derivative Liability Rent expenses Warrants issued to purchase common stock Exercise price (in dollars per share) Option excersice price (in dollars per share) Warrant expiration period Gross proceeds from capital raising transactions Stock issued during period, shares Value of number of shares issued Conversion price (in dollars per share) Reduction in conversion price (in dollars per share) Number of shares issued upon conversion Principal amount of senior convertible debentures Number of shares converted Amount of shares converted Number of common shares purchased Preferred stock, par value (in dollars per share) Securities sold Percentage of shares acquired Preferred stock, outstanding Beneficial ownership limitation Deemed dividend Total stock-based compensation expense Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Outstanding at beginning Granted Forfeited Outstanding at ending Exercisable at ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] Outstanding at beginning Granted Forfeited Outstanding at ending Exercisable at ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Roll Forward] Outstanding at ending Exercisable at ending Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Roll Forward] Outstanding at ending Exercisable at ending Number of shares [Roll Forward] Outstanding at beginning Issued Expired Outstanding at ending Exercisable at ending Weighted-average exercise price [Roll Forward] Outstanding at beginning Issued Expired Outstanding at ending Exercisable at ending Weighted-average remaining contractual term [Roll Forward] Outstanding at ending Aggregate intrinsic value [Roll Forward] Number of shares Weighted Average Exercise price Expiration date begenning Expiration date ending Exercise price of warrant (in dollars per share) Common stock,issued Common stock,value Payment or cancellation debt Proceeds from debt Received cash from debt Conversion price Maturity date Discreiption of convertible debentures Percentage of outstanding debentures Percentage of partial liquidated damages fee for each investor Percentage of securities issued investors Cash Prepaid expenses Equipment Goodwill Total assets acquired Accounts payable and other liabilities Total Revenue Net loss attributable to common shareholders Net loss per share (in dollars per share) Percentage of ownership acquired Number of shars issued upon acquistion (Purchase consideration) Number of shares issued upon acquistion, value (Purchase consideration) Number of shares held in escrow account Number of shares received by shareholders (5% of the payment shares) Value of revenue and loss Value of revenue and loss Subsequent Event [Table] Subsequent Event [Line Items] Face amount Debt face amount in cash Interest rate Maturity Date Debt cancellation amount Interest rate terms Debt maturity term Maturity date, description Terms of conversion feature Partial liquidated damages fee percentage Future offerings period Ownership percentage Number of share issued in conversion of debt Preferred stock, authorized Preferred stock, par value Preferred stock, stated value Reverse stock split Preferred stock issued Proceeds from issuance of convertible preferred stock Carrying value as of the balance sheet date of obligations incurred and payable for research and development. Change in fair value of derivative liability during the period. Information by type of related party. Preferred stock that may be exchanged into common shares or other types of securities at the owner's option. Information of effect of asu no.2017 11 on previously issued financial statements. Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements. Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements. Exercise price per share or per unit of warrants or rights outstanding. It represents as a expiration date begenning. It represents as a expiration date ending. It refers to the amount of liability reclassified as fair value. It represents the amount of finance cost paid during the period. Information by plan name pertaining to equity-based compensation arrangements. Information by plan name pertaining to equity-based compensation arrangements. Information by plan name pertaining to equity-based compensation arrangements. Information by plan name pertaining to equity-based compensation arrangements. Represents financing 2017 member. Infomation about future offerings period. Value of gross proceeds from capital raising transactions. Amount refers to increase (decrease) in receivable sale of preferred stock. Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. Information by business combination or series of individually immaterial business combinations. The entire disclosure of management plans to continue as a going concern. It represents of number of shares held in escrow account. It represents of number of shares received by shareholders. As partial liquidated damages, a fee of each Investor’s initial principal amount of such Investor’s Debenture in cash. It represents of payment from convertible debt cash received. It represents of percentage of outstanding debentures. It represents of percentage of partial liquidated damages fee for each investor. It represents of percentage of securities issued investors. Share of preferred stock and warrants issued during the period. Value of preferred stock and warrants issued during the period. Face amount value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Face amount stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements. Information about agreement. Information by category of arrangement, Information by type of debt instrument, including, but not limited to, draws against credit facilities. Represents series B and C preferred stock member. Information by type of debt instrument, including, but not limited to, draws against credit facilities. Preferred stock that may be exchanged into common shares or other types of securities at the owner's option. The number of shares into which fully or partially vested equity intrument other than options exercisable as of the balance sheet date. The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of equity instruments other than options outstanding and currently exercisable under the stock option plan. The weighted average exercise price forfeited for warrants during the period. The weighted average exercise price granted for warrants during the period. The number of equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. The weighted average exercise price for outstanding warrants. A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. Information about agreement. Value of stock and warrants issued during the period for the payment of consulting fees. Number of shares issued during the period as a result of the conversion of convertible securities. The gross value of stock issued during the period upon the conversion of convertible securities. Represents the warrants expiration period. It represents the amount of warrants issued to purchase shares of common stock. Information by the different classes of stock of the entity. Information by the different classes of stock of the entity. Information by the different classes of stock of the entity. Preferred stock conversion price per common share. Represents the beneficial ownership limitation. Represents the information pertaining to preferred stock and warrants. The entire disclosure for warrant. Preferred Stock Dividends and Other Adjustments Shares, Issued Share-based Compensation ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumber Increase (Decrease) in Prepaid Expense and Other Assets Payments to Acquire Property, Plant, and Equipment Derivative Liability [Default Label] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Redeemable Preferred Stock Dividends Change in Fair Value Of Derivative Liability Increase (Decrease) in Receivables Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNumber [Default Label] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Business Acquisition, Pro Forma Net Income (Loss) Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual